fenofibrate All Financial Data in US $ (mln)

Latest News

Interim Results Announcement for the Six Months Ended 30 June, 2016
Sino Biopharmaceutical (August 26, 2016)
Announcement of Interim Results for the Six Months Ended 30 June 2016
Sihuan Pharmaceutical Holdings Group (August 23, 2016)
ANI Pharmaceuticals Reports Record Second Quarter Results and Increases Full-year 2016 Guidance
ANI Pharmaceuticals (August 04, 2016)

Displaying 3 out of a possible 630 unique stories.
Results Sorted By date

EvaluatePharma® - the premier source for pharma and biotech analysis.

Expert integration of financial and product data across historic and forecast timeframes (1986 to 2018) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status, deals, license revenues and much more.

Summary Generic Name Information

Generic Name: fenofibrate
Therapeutic Subcategory:     Anti-hyperlipidaemics

Product Sales Summary

Annual Sales WW - Sales Growth per Year (%)
Rank1 ProductProduct CompanyCompany 2014 2015 2015
Generic Name:2 fenofibrate 706 297 (58%)
Note: Shaded Cells3

Evaluate - intelligence you can act on

Evaluate delivers market intelligence with standardized, transparent, integrated data that clients rely on.

Choose from a vast array of dynamic reports, customize, edit and download to PDF, Excel or create bespoke reports with expert client support.

Explore Content & Tools


Evaluate provides market intelligence and analysis for the pharma, biotech and medtech industries.

Explore Evaluate

Register to access more FREE content:

  • 2011 Product Sales analysis
  • Download to Excel
  • Search 2 yrs of company press releases

Register for Free Analysis

Register to access more free insights and analysis from Evaluate.  

Register Now